Abstract: Abnormal contraction of vessels termed 'vasospasm' is associated with various cardiovascular diseases. Smoking is a well-known risk factor that increases vasospasm. However, the molecular mechanisms by which smoking leads to vasospasm and cardiovascular disease are not fully understood. This study was designed to examine whether DMSO-extracted cigarette smoke particles (DSP) could induce up-regulation of vascular endothelin type A (ET A ) receptors, and whether ET A receptor is up-regulated through activation of extracellular regulated protein kinases 1 and 2 (ERK1/2) signal pathways. Mesenteric arterial segments from rats were cultured in the presence of DSP, water-extracted cigarette smoke particles (WSP) or equivalent concentration of nicotine for up to 24 hr. The results showed that DSP, but not WSP or nicotine, induced ET A receptor up-regulation with increased ET A receptor-mediated contraction (myograph, p < 0.001). Simultaneously, the expression of ET A receptor mRNA (real-time PCR, p < 0.001) and protein (immunohistochemistry) were enhanced in the smooth muscle cells, suggesting that the lipid-soluble substances contained in cigarette smoke were responsible for the effects of DSP. Actinomycin D (a general transcriptional inhibitor) decreased ET A receptor mRNA expression and attenuated receptor-mediated contraction (p < 0.001), while DSP accelerated ET A receptor mRNA degradation (p < 0.01) and promoted the translation of ET A receptor mRNA into protein. Furthermore, the up-regulation of ET A receptors was significantly attenuated by inhibition of ERK1/2 signal pathways (p < 0.001). In conclusion, DSP most likely activate ERK1/2 signal pathway-mediated transcriptional and post-transcriptional (translational) mechanisms that lead to vascular ET A receptor up-regulation, which might contribute to vasospasm and the development of smoking-associated cardiovascular diseases.
Abnormal contraction of vessels, termed 'vasospasm', results in tissue ischaemia and necrosis and plays a key role in the development of cardiovascular diseases. Functional disorders of coronary circulation lead to coronary artery vasospasm (vasospastic angina) that contributes to the development of myocardial ischaemia [1] and myocardial infarction [2] . Cigarette smoking strongly increases the risk of the development of peripheral arterial disease, coronary heart disease and stroke [3] . In particular, smoking is the strongest risk factor for inducing coronary artery vasospasm [1, 4] , as many other conventional risk factors for atherosclerosis do not appear to be responsible for inducing vasospastic angina [1] . In addition, independent of other cardiovascular risk factors, passive smoking per se increases the risk of cardiovascular disease by 25-30% [5] . However, the underlying molecular mechanisms by which smoking leads to vasospasm and the development of cardiovascular disease are still not fully understood.
Endothelin-1 (ET-1) is a potent vasoconstrictor and a growth factor for vascular smooth muscle cells. It acts on its two specific receptors named endothelin type A (ET A ) and type B (ET B ) receptors. The ET A and ET B receptors regulate vascular smooth muscle contraction, proliferation and vascular remodelling [6] . Circulating levels of ET-1 have been shown to be substantially elevated in patients with chronic heart failure [7] and chronic thromboembolic pulmonary hypertension [8] . The ET-1 levels correlate with the severity of diseases, suggesting an important role of endothelin system in cardiovascular pathogenesis. Normally, the ET A receptors are expressed on vascular smooth muscle, mediating contraction and proliferation, and the ET B receptors are located on vascular endothelial cells inducing vasodilation via nitric oxide and prostacyclin pathways. However, under pathological conditions, contractile ET B receptors are induced to express in vascular smooth muscle cells and mediate vasoconstriction [6] . In patients suffering from hypertension and ischaemic heart disease, both ET A and ET B receptors in the smooth muscle were up-regulated [9] [10] [11] . The up-regulation of endothelin receptors mediates the vascular smooth muscle cell hyper-reactivity to ET-1, which subsequently results in abnormal contraction (vasospasm) and adverse proliferation (remodelling) of the vasculature [12] . The induced up-regulation of ET B receptor expression under pathological condition has been extensively studied, and it has been revealed that activation of mitogenactivated protein kinases (MAPK) mediates the contractile ET B receptor up-regulation [6] , while it is less known how the risk factors up-regulate vascular ET A receptors.
We have demonstrated that rats exposed to passive cigarette smoke exhibited up-regulation of both ET A and contractile ET B receptors in the coronary artery through activation of the MAPK pathways [13] , suggesting that cigarette smoke exposure might result in coronary artery spasm via up-regulation of endothelin receptors in the vascular smooth muscle cells. To further understand the underlying molecular mechanisms, this study was designed to examine whether lipid-soluble smoke substances contained in cigarette smoke induced up-regulation of ET A receptors in rat mesenteric arteries in vitro, and whether the activation of extracellular regulated protein kinases 1 and 2 (ERK1/2) signal pathways was involved. Understanding the intracellular signalling mechanisms that lead to vascular ET A receptor up-regulation and hyper-reactivity to ET-1 may provide new options for prevention and treatment of vasospasm and smoking-associated cardiovascular disease.
Materials and Methods
Extraction of DSP. Cigarettes (Marlboro, 0.8 mg nicotine per cigarette) were 'smoked' by an aspirator, and the smoke was directed through a cotton wool filter. The retained smoke particles from three cigarettes in the filter were dissolved in either 1 ml of dimethyl sulphoxide (DMSO)-extracted smoking particles (DSP) or in 1 ml of distilled water-extracted smoking particles (WSP) and were diluted to a standard nicotine content of 0.1 mg/ml. These stock solutions were kept at À20°C for all subsequent experiments.
Tissue preparation and organ culture procedure. Sixty male Sprague Dawley rats (body-weight 300-350 g) were anaesthetized with CO 2 and exsanguinated. The superior mesenteric artery was gently removed, immersed in cold physiologic buffer solution and freed of adhering tissue under a dissection microscope. The endothelium was denuded by perfusion of the vessel for 10 sec. with 0.1% Triton X-100 followed by another 10 sec. with a physiologic buffer solution. The vessels were then cut into 1-mm-long cylindrical segments and incubated for 12 or 24 hr at 37°C in humidified 5% CO 2 in air. Organ culture of the arterial ring segments in the presence of DSP or equivalent volume of DMSO (control) was performed in a 24-well plate, with two segments per well in 1 ml of Dulbecco's modified Eagle's medium (DMEM) containing L-glutamine (584 mg/l) that was supplemented with penicillin (100 U/ml) and streptomycin (100 lg/ ml). The present investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996), and the experimental protocol was approved by the Ethic Committee of Lund University.
In vitro pharmacology. The arterial ring segments were immersed in temperature-controlled (37°C) myographs (Organ Bath Model 700MO, J.P. Trading, Aarhus, Denmark) containing 5 ml of bicarbonate buffer solution. The solution was continuously aerated with 5% CO 2 in O 2 resulting in a pH of 7.4. The arterial segments were mounted for continuous recording of isometric tension with the Chart software (ADInstruments, Hastings, UK). A resting tone of 2.5 mN was applied to each segment, and the segments were allowed to stabilize at this tension for at least 1.5 hr before exposure to a potassium-rich (60 mM K + ) buffer solution. The potassium-induced contraction was used as a reference for contractile capacity, and the segments were used only if potassium elicited reproducible responses over 1.0 mN.
Concentration-response curves for ET-1 (non-selective ET A and ET B receptor agonist) were obtained by cumulative administration of the peptide, after the ET B receptor had been desensitized in the arterial ring segments. Desensitization of ET B receptors in the arterial segments was achieved by administration of sarafotoxin 6c (S6c). Briefly, a S6c concentration-effect curve was performed first, and the segments remained in contact with the highest concentration of S6c (100 nM) for a further 30 min. During the 30-min. period, the contractile response to S6c faded to the baseline levels even though S6c still remained in contact with the segments. The desensitization of ET B receptors was verified by the absence of response to a further increase in the S6c concentration to 300 nM at the end of this period. After ET B receptors had been desensitized, ET-1 concentration-effect curves were performed. Thus, in the experimental set-up used in the present study, the contractile response to ET-1 was mediated by the ET A receptors. This method is comparable to the application of selective ET B receptor antagonist BQ-788 in the mesenteric arteries [14] .
Real-time reverse transcription (RT)-PCR. The arterial ring segments were homogenized in 1 ml of the RNApro solution (Q-BIOgene, Carlsberg, CA, USA) performed with a FastPrep instrument (QBIOgene). Total RNA was extracted and reversely transcribed to cDNA. The real-time quantitative RT-PCR was performed with the GeneAmp SYBR Green PCR kit in a GeneAmp 5700 sequence detection system (Perkin-Elmer, Waltham, MA, USA).
The PCR was performed in a total volume of 50 ll and started at a temperature of 50°C for 2 min., 95°C for 10 min. and 40 PCR cycles of 95°C for 15 sec. and 60°C for 1 min. Dissociation curves were run after the real-time PCR to identify the specific PCR products. All primers were designed using Primer Express 2.0 (PE Applied Biosystems, Foster city, CA, USA) and synthesized by TAG Copenhagen A/ S (Copenhagen, Denmark). Specific primers for the rat ET A receptor (GeneBank ID: NM-012550.2) mRNA and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH, GeneBank ID: NM-023964) mRNA are listed in table 1 . GAPDH was used as references as it is continuously expressed at a constant amount in cells.
Data were analysed with the comparative cycle threshold (C T ) method. To evaluate the amount of ET A receptor mRNA in a sample, GAPDH mRNA were assessed in the same sample simultaneously. The C T values of GAPDH mRNA were used as a reference to quantify the relative amount of target mRNA. The relative amount of mRNA was calculated with the C T values of ET A receptor mRNA in relation to the C T values of GAPDH mRNA in the sample.
Immunohistochemistry study. After organ culture in the presence of DMSO (0.2 ll/ml) or DSP (0.2 ll/ml) for 24 hr, the arterial segments were immersed in 4% paraformaldehyde in 0.1 mol/l phosphate buffer (pH 7.4) for 3 hr at 4°C. After fixation, specimens were dehydrated in phosphate buffer (0.1 mol/l, pH 7.4) containing 20% sucrose for 24 hr at 4°C, embedded, frozen in Tissue-Tek (Sakura Finetek Europe B.V., Zoeterwoude, Netherlands) and then stored at À80°C. Cryostat 1C ) had similar effects, that is increase in ET A receptor-mediated contraction with E max from 281.8 AE 9.12 to 544.6 AE 27.78 (p < 0.001). The maximum effect of DSP was reached at 0.2 ll/ml for 24 hr. Organ culture for 24 hr in the presence of WSP or the equivalent concentration of nicotine (0.028 lg/ml) as contained in DSP (0.2 ll/ml) had no effect ( fig. 1D ).
Results

Up-regulation of ET
The expression of ET A receptor mRNA was analysed by quantitative real-time PCR. The level of ET A receptor mRNA in the arterial segments elevated after exposure to DSP for 24 hr (fig. 1E , p < 0.001).
Endothelin type A receptor protein expression was visualized by immunohistochemistry with confocal microscopy. Compared to the solvent DMSO ( fig. 2A) , an increased ET A receptor protein was seen in the arterial smooth muscle cells after exposure to DSP for 24 hr (fig. 2B ). fig. 3C , p < 0.01), suggesting that a posttranscriptional (translational) mechanism is also responsible for the effects of DSP.
Increased transcription and translation of ET
Inhibition of ERK1/2 signal pathways by their specific inhibitors.
We employed specific inhibitors to block ERK1/2 signal pathways (PD98059, fig. 4A, and U0126, fig. 4B ), respectively. Inhibition of ERK1/2 signal pathways significantly abolished the DSP-increased ET A receptor-mediated contraction ( fig. 4A ,B, p < 0.01). Inhibition of ERK1/2 signal pathways resulted in a tendency of increase in the level of ET A receptor mRNA expression ( fig. 4C , p > 0.05). Apparently, inhibition of ERK1/2 signal pathways had similar effects as inhibition of translation by cycloheximide did, that is abolished the effects of DSP on ET A receptor-mediated contraction ( fig. 3B ) and the receptor mRNA degradation ( fig. 3C) , suggesting that the activation of ERK1/2 signal pathways by DSP enhanced the ET A receptor translation.
Discussion
Vascular endothelin receptor up-regulation is seen in cardiovascular disease [9, 11] and in passively smoke-exposed rats [13] . The up-regulation of endothelin receptors results in vascular hyper-reactivity to the endogenous receptor agonist ET-1, a potent vasoconstrictor that plays an important role in the development of cardiovascular disease. ET-1 induces both vasoconstriction and smooth muscle cell proliferation [12] , leading to vasospasm and subsequent ischaemia. The present study has demonstrated for the first time that the lipid-soluble substances contained in cigarette smoke are primarily responsible for smoke-induced vascular hyper-reactivity to ET-1 via the up-regulation of ET A receptors. The activation of ERK1/2 signal pathways by DSP induced an increase in transcription and post-transcription (translation) of the ET A receptors, which mediated smoke-induced vascular hyper-reactivity to ET-1. The up-regulation of endothelin receptors leads to vascular hyper-reactivity to ET-1 and thus limits local blood flow, which may contribute to the development of ischaemic cardiovascular disease [15] [16] [17] .
Previously, we found that exposure of rats to cigarette smoke resulted in up-regulation of coronary artery endothelin receptors [13] . Similarly, rat mesenteric artery segments exposed to DSP in vitro induced the ET B receptor up-regulation via activation of ERK1/2 and p38 signal pathways [18] . 
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the smooth muscle cells is most likely mediated by both transcriptional and post-transcriptional mechanisms ( fig. 4D ).
It is well-known that promotion of mRNA translation into protein is a strong and direct factor for accelerating the mRNA degradation [19, 20] . In the present study, DSP promoted ET A receptor translation, and subsequently accelerated ET A receptor mRNA degradation. However, an overweight of transcription of ET A receptor mRNA in the balance of the mRNA transcription and degradation was suggested by our results that, DSP significantly induced an elevated level of ET A receptor mRNA expression in the smooth muscle cells. Furthermore, the protein synthesis inhibitor cycloheximide inhibited ET A receptor translation and subsequently resulted in accumulation of ET A receptor mRNA. A similar phenomenon has been seen in the cell culture of human colon cancer cells, where increased expression of urokinase plasminogen activator (uPA) mRNA was induced after the addition of cycloheximide [21] . More interestingly, inhibition of ERK1/2 signal pathways significantly attenuated the effects of DSP mentioned above, indicating that ERK1/2 signal pathways were involved in the promotion of ET A receptor mRNA transcription and post-transcription (translation).
The nicotine concentration used in the present study is similar to serum level of nicotine in individuals during cigarette smoking [22] . The WSP or nicotine (equivalent to the concentration in DSP) per se did not induce changes in ET A receptor expression in arterial smooth muscle cells, proved that it was the lipid-soluble cigarette smoke particles that were responsible for the effects of DSP. A previous study showed that nicotine injection significantly increased the mean arterial pressure in rats in vivo; antagonism of ET A receptors (with JKC301) but not ET B receptors (with BQ-788) attenuated nicotine-increased blood pressure [23] . It is most likely that the acute administration of nicotine stimulated ET-1 secretion from the endothelial cells, while JKC301 blocked the effects of ET-1 on ET A receptors in vascular smooth muscle cells, and thus retarded the vasoconstriction induced by nicotine. Interestingly, clinical studies have revealed that when tobacco is smoked, it causes a high incidence of atherosclerotic cardiovascular disease, whereas chewing tobacco, moist snuff or nicotine replacement does not have as high cardiovascular risks associated as smoking [24] [25] [26] . The lipid-soluble particles contained in DSP might be up-taken via the lung alveolar membrane into the blood and then transported by low-density lipoprotein to the arterial wall [27] , where they participate in atherosclerotic plaque formation with increased endothelin receptor expression [28] .
There are two local conditions for inducing vasospasm. Firstly, vascular smooth muscle cell is hyper-reactive to vasoconstrictors like ET-1; and secondly, enough vasoconstrictors exist locally to induce vasospasm [29] . Blockage of the ERK1/2 signal pathways abolished smoke particle-induced ET A receptor up-regulation and significantly decreased ET A receptor-mediated contractile response of the smooth muscle cells, suggesting that the ERK1/2 signal pathways may play a key role in smoke-associated vasospasm such as coronary artery spasm [1, 4] . A recent clinical study showed that sildenafil inhibited pulmonary artery endothelial and smooth muscle cell to mesenchymal transition by inhibition of ERK1/2 and SMAD3 phosphorylation [30] . These findings suggested that ERK1/2 activation might contribute to vascular diseases; particularly those associated with altered vascular contractility, and thus, the inhibition of ERK1/2 could be beneficial for the prevention and treatment.
There are some limitations of the present study, that is the vessels lack blood flow during organ culture, and thus, it is different from the physiological conditions. In addition to this, the endothelium was removed, so the interaction between endothelial cells and smooth muscle cells could not be involved. More than 4000 substances were identified in cigarette smoke [31] . Unfortunately, we were unable to clarify which substance(s) are directly involved in the present study.
In conclusion, lipid-soluble substances contained in smoke induced up-regulation of ET A receptors in vascular smooth muscle cells and increased contraction. The up-regulation of ET A receptors occurred at transcriptional and post-transcriptional levels, and the activation of ERK1/2 signal pathways was involved. Inhibition of ET A receptor up-regulation by blockage of ERK1/2 signal pathway might normalize the smooth muscle cell hyper-reactivity to ET-1, and thus provide new options for the prevention and treatment of vasospasm and smoking-associated ischaemic cardiovascular disease.
